Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research

Kontsevaya, A. V.; Bates, Katie; Goryachkin, E; Bobrova, Natalia; Сыромятникова, Л И; Popova, Yulia V.; Platonov, D. Yu.; Осипова, И. В.; Недбайкин, А. М.; Malorodova, T.N.; Mirolyubova, O. A.; Kryuchkov, D.V.; Хаишева, Л. А.; Galyavich, А. S.; Franz, Marcus; Efanov, А. Yu.; Duplyakov, D. V.; Drapkina, О. М.; Leon, David A.; McKee, Martin

doi:10.20996/1819-6446-2018-14-4-474-487

Cited by 6 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В целом отмечается позитивная тенденция к увеличению объема реперфузионных вмешательств у пациентов с ОКСпST, что характерно и для других российских регионов [14,15], а также стран Европы и Серверной Америки [12]. Этот важный показатель ассоциирован не только со снижением госпитальной летальности, но и с улучшением отдаленного прогноза [16][17][18][19].…”

Section: реперфузионная стратегия при окс со стойким подъемом St в реunclassified

Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register

Скопец

Везикова

Малафеев³

et al. 2020

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

Aim. To study the clinical course, treatment, and outcomes in the patients with ST segment elevation acute coronary syndrome (STeACS) in real clinical practiceMaterial and methods. Our study is based on data of 5694 patients who were sequentially hospitalized in the Regional Vascular Center from 01.01.2009 to 01.01.2019 due to STeACS and included in the Federal Hospital Register. Men prevailed (65.8%); the average age was 68 years old. 14.1% of the patients had the history of myocardial infarction (MI) before this hospitalization. The reperfusion strategy, drug therapy, as well as the risks of complications and outcomes in real clinical practice of the Republic of Karelia were analyzed. Descriptive statistics methods were used to evaluate the results.Results. In the study group a high frequency of reperfusion interventions (83.5%) with a predominance of percutaneous coronary intervention (PCI; 76.2%) was revealed, as well as optimal drug therapy in most patients. Thus, 99.4% of patients took aspirin, 82.8% – clopidogrel, 91.1% – anticoagulants, 91.6% – beta-blockers, 95.6% – statins, 94.2% – angiotensin-converting-enzyme inhibitors/angiotensin II receptors blockers. A risk assessment of hospital and 6-month mortality was performed using GRACE score. The distribution of the hospital risk mortality were the following: 25.7% of patients had a low (49-125 points), 33.7% an average (126-154 points), and 40.6% of patients had a high risk (more than 154 points). At the same time, the risk of 6-month mortality in a half of the patients (51.6%) was low (27-99 points), the average risk (100-127 points) was determined in 23.0% of patients and the high risk (more than 127 points) – in 25.5% of patients. Life threatening complications developed in 38.1% of patients and the most frequent ones were arrhythmias (31.5%). The outcomes at the discharge from the hospital were as follows: 1432 patients (63.5%) had Q MI, 390 (17.3%) – non Q MI, 76 (3.4%) – unstable angina, 21 (0.9%) – MI of unspecified localization and 317 patients (14.1%) – repeated myocardial infarction.Conclusion. According to the results of a 10-year hospital registry of patients with STeACS, a high frequency of reperfusion interventions and an optimal drug therapy in most patients was revealed. However, to increase the effectiveness of treatment, it is necessary to minimize temporary losses both at the prehospital treatment and during reperfusion.

show abstract

Section: реперфузионная стратегия при окс со стойким подъемом St в реunclassified

Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register

Скопец

Везикова

Малафеев³

et al. 2020

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

show abstract

“…Одной из причин такой катастрофически высокой смертности являются быстрое прогрессирование заболевания при несвоевременном его выявлении, а также неправильно подобранное лечение и появление смертельно опасных осложнений со стороны органов-мишеней (цереброваскулярных, сердечно-сосудистых и почечных) [5][6][7].…”

Section: Introductionunclassified

Etiopathogenesis, diagnosis, and approaches to the treatment of arterial hypertension: an assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project

et al. 2021

View full text Add to dashboard Cite

Introduction. Arterial hypertension (AH) is a syndrome accompanied by an increase in systolic blood pressure (BP)140 mmHg and/or diastolic BP90 mmHg. It is a progressive pathology that affects the adult employable population and leads to the development of deadly complications. Aim. To compare the level of physicians knowledge in AHs definition, diagnosis and treatment in different centers of Russia. Materials and methods. In the framework of the multicenter study PHYSTARH (the full name of the project Physicians and undergraduates knowledge in arterial hypertension treatment), which was launched in 2017, an anonymous survey was conducted among 425 doctors from 9 cities/regions of Russia (Belgorod Region, Moscow, Krasnodar Territory, the Republic of Adygea, Voronezh, Primorye Territory, Tatarstan, Lipetsk, Chelyabinsk). Results. The study revealed an insufficient level of doctors knowledge in diagnosis and treatment of AH. Less than half of the respondents correctly answered the following questions: determining hypertension by the level of home monitoring of BP (36% of physicians), determining the degree of hypertension for the proposed numerical values (37% of physicians), definition and prevalence of the refractory hypertension (33% of physicians), definition of the masked hypertension (45% of physicians), the need for drug correction of high normal BP (9% of physicians), selection of the main classes of antihypertensive drugs without clinical situations (26% of physicians). Conclusion. The physicians knowledge on AH is unsatisfactory, despite the prevalence of pathology and the availability of clinical guidelines, which, in our view, justifies the need for additional public education programs for doctors in different regions.

show abstract

Unresolved issues of increasing physical activity after myocardial infarction

Sedykh¹,

Hryachkova²,

Кривошапова³

et al. 2022

Russ J Cardiol

View full text Add to dashboard Cite

The review presents the results of studies on the problems of increasing the efficiency of rational physical activity within the concept of comprehensive secondary prevention of myocardial infarction. The aspects of insufficient adherence of specialists and patients to rehabilitation methods were discussed; possible safe exercise modes after infarction and available monitoring methods were given. We also described the potential characteristics of physical training, taking into account the initial clinical severity and completeness of revascularization after myocardial infarction. In addition, the need for socio-economic, as well as informational support of the state and healthcare system has been updated.

show abstract

Hospital Stage of Myocardial Infarction Treatment in 13 Regions of Russian Federation by Results of the International Research

Cited by 6 publications

References 16 publications

Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register

Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register

Etiopathogenesis, diagnosis, and approaches to the treatment of arterial hypertension: an assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project

Unresolved issues of increasing physical activity after myocardial infarction

Contact Info

Product

Resources

About